Carla Leibowitz is Chief BD Officer at Paige.AI. Prior, she led Corporate Development and Strategy at Arterys, the first company to achieve FDA clearances for several products that combine cloud computing and artificial intelligence. She has an MBA from the Stanford Graduate School of Business and engineering degrees from both MIT and Stanford. Prior to joining Arterys, Carla spent 3 years at Bain & Company, consulting for top biotech, diagnostic and hospital clients. At the beginning of her career, Carla designed medical devices and led device development teams at several companies and has more than 16 patents under her name.
AI & Data Sciences Showcases:
Paige builds software to advance diagnosis, treatment and biomarker discovery for cancer.
Clinical-grade AI: Definition, Creation, and Validation
Paige builds clinical-grade computational pathology assays for both clinical and research labs to draw new insights and build new biomarkers from pathology data. This talk will cover how we define clinical grade and assess clinical grade and how we have created multiple solutions that meet this standard.
The PMWC 2020 AI Company Showcase will provide a 15-minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.